Lung function in patients with diabetes mellitus;Fonction pulmonaire du patient diabétique

Revue de Pneumologie Clinique

Volumn 72, Issue 1, 2016, Pages 10-16

  Fontaine Delaruelle, C ^a,b   Viart Ferber, C ^a,b   Luyton, C ^a,b   Couraud, S ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Alveolar diffusion capacity; Diabetes mellitus; Lung function; Pulmonary function test

Indexed keywords

ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIFFUSING CAPACITY OF LUNG FOR CARBON MONOXIDE; EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INSULIN TREATMENT; KIDNEY FAILURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; OBESITY; RESIDUAL VOLUME; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY; VASCULAR DISEASE; ADULT; FEMALE; LUNG; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

CARBON MONOXIDE;

ADULT; CARBON MONOXIDE; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 84957844747     PISSN: 07618417     EISSN: 17762561     Source Type: Journal    
DOI: 10.1016/j.pneumo.2015.03.010     Document Type: Article

References (22)

1. American Diabetes Association Standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S14-S80.
2. Van den Borst B., Gosker H.R., Zeegers M.P., Schols A.M.W.J. Pulmonary function in diabetes: a metaanalysis. Chest 2010, 138:393-406.
3. Sandler M. Is the lung a « target organ » in diabetes mellitus?. Arch Intern Med 1990, 150:1385-1388.
4. Laube BL. Treating diabetes with aerosolized insulin. Chest 200;120(Suppl):99S- 106S.
5. Hsia C.C.W., Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005, 118(3):205-211.
6. Hughes J.M.B., Pride N.B. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med 2012, 186:132-139.
7. Bell D., Collier A., Matthews D.M., Cooksey E.J., McHardy G.J., Clarke B.F. Are reduced lung volumes in IDDM due to defect in connective tissue?. Diabetes 1988, 37:829-831.
8. Anandhalakshmi S., Manikandan S., Ganeshkumar P., Ramachandran C. Alveolar gas exchange and pulmonary functions in patients with type ii diabetes mellitus. J Clin Diagn Res JCDR 2013, 7:1874-1877.
9. Cooper B.G., Taylor R., Alberti K.G., Gibson G.J. Lung function in patients with diabetes mellitus. Respir Med 1990, 84:235-239.
10. Klein O.L., Kalhan R., Williams M.V., Tipping M., Lee J., Peng J., et al. Lung spirometry parameters and diffusion capacity are decreased in patients with type 2 diabetes. Diabet Med J Br Diabet Assoc 2012, 29:212-219.
11. Ozşahin K., Tuğrul A., Mert S., Yüksel M., Tuğrul G. Evaluation of pulmonary alveolo-capillary permeability in type 2 diabetes mellitus: using technetium 99mTc-DTPA aerosol scintigraphy and carbon monoxide diffusion capacity. J Diabetes Complications 2006, 20:205-209.
12. Saler T., Cakmak G., Saglam Z.A., Ataoglu E., Yesim Erdem T., Yenigun M. The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria. Intern Med Tokyo Jpn 2009, 48:1939-1943.
13. Chance W.W., Rhee C., Yilmaz C., Dane D.M., Pruneda M.L., Raskin P., et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 2008, 31:1596-1601.
14. Guvener N., Tutuncu N.B., Akcay S., Eyuboglu F., Gokcel A. Alveolar gas exchange in patients with type 2 diabetes mellitus. Endocr J 2003, 50:663-667.
15. Marvisi M., Bartolini L., del Borrello P., Brianti M., Marani G., Guariglia A., et al. Pulmonary function in non-insulin-dependent diabetes mellitus. Respir Int Rev Thorac Dis 2001, 68:268-272.
16. Ljubić S., Metelko Z., Car N., Roglić G., Drazić Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998, 114:1033-1035.
17. Klein O.L., Jones M., Lee J., Collard H.R., Smith L.J. Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure. Diabetes Res Clin Pract 2012, 96:e73-e75.
18. Weynand B., Jonckheere A., Frans A., Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respir Int Rev Thorac Dis 1999, 66:14-19.
19. Vracko R., Thorning D., Huang T.W. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979, 120:973-983.
20. Pitocco D., Fuso L., Conte E.G., Zaccardi F., Condoluci C., Scavone G., et al. The diabetic lung-new target organ?. Rev Diabet Stud RDS 2012, 9:23-35.
21. Yeh H.-C., Punjabi N.M., Wang N.-Y., Pankow J.S., Duncan B.B., Cox C.E., et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008, 31:741-746.
22. Raskin P., Heller S., Honka M., Chang P.-C., Boss A.H., Richardson P.C., et al. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled technosphere insulin or usual antidiabetes treatment: a randomized trial. Diabetes Obes Metab 2012, 14:163-173.